Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Mar 5;14:1756286421999631. doi: 10.1177/1756286421999631

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s), 2021

This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).

PMC Copyright notice

Figure 1. — (a) Distribution of types of CIN in the whole cohort. (b) Distribution of types of CIN in the patients receiving CYP, RTX, and/or BTZ. (c) Proportion of patients receiving CYP, RTX, and/or BTZ per group.

BTZ, bortezomib; CIDP, chronic inflammatory demyelination polyneuropathy; CIN, chronic immune-mediated sensorimotor neuropathies; CYP, cyclophosphamide; MADSAM, Lewis-Sumner syndrome/multifocal acquired demyelinating sensory and motor neuropathy; PDN, paraproteinemic demyelinating neuropathy; RTX, rituximab.